11q13 is a cytogenetically promiscuous site in hematologic malignancies

Area of Science:

• Hematology
• Oncology
• Cytogenetics

Background:

• The 11q13 translocation, specifically t(11;14)(q13;q32), is a known hallmark of mantle cell lymphoma, often involving cyclin D1 gene rearrangement and overexpression.
• Emerging evidence highlights a connection between 11q13 abnormalities and acute myeloid leukemia (AML).

Purpose of the Study:

• To investigate the presence and significance of 11q13 translocations in acute leukemias and myelodysplastic syndromes (MDS).
• To explore potential genetic mechanisms driving tumorigenesis in these hematologic malignancies, independent of cyclin D1.
• To characterize the cytogenetic promiscuity of the 11q13 region in various cancers.

Main Methods:

• Cytogenetic analysis of patients diagnosed with acute leukemias and myelodysplastic syndromes.
• Molecular studies to assess gene rearrangements and expression, particularly focusing on the 11q13 region.
• Comparative analysis of translocation patterns across myeloid and lymphoid malignancies.

Main Results:

• Confirmed the occurrence of 11q13 translocations in both acute leukemias and MDS.
• Identified that 11q13 is a frequently involved site in reciprocal translocations across diverse hematologic malignancies.
• Observed that these translocations involve various chromosomal partners, indicating a broader role in oncogenesis.

Conclusions:

• 11q13 translocations are implicated in the pathogenesis of both acute myeloid leukemia and myelodysplastic syndromes.
• Genetic mechanisms other than cyclin D1 dysregulation may contribute to 11q13-associated leukemogenesis.
• The 11q13 chromosomal region is a cytogenetically unstable locus prone to translocations in both myeloid and lymphoid cancers.